DOI QR코드

DOI QR Code

Hepatitis Delta Virus Large Antigen Sensitizes to TNF-α-Induced NF-κB Signaling

  • Park, Chul-Yong (Ilsong Institute of Life Science, Hallym University) ;
  • Oh, Sang-Heun (Ilsong Institute of Life Science, Hallym University) ;
  • Kang, Sang Min (Ilsong Institute of Life Science, Hallym University) ;
  • Lim, Yun-Sook (Ilsong Institute of Life Science, Hallym University) ;
  • Hwang, Soon B. (Ilsong Institute of Life Science, Hallym University)
  • Received : 2009.05.06
  • Accepted : 2009.05.22
  • Published : 2009.07.31

Abstract

Hepatitis delta virus (HDV) infection causes fulminant hepatitis and liver cirrhosis. To elucidate the molecular mechanism of HDV pathogenesis, we examined the effects of HDV viral proteins, the small hepatitis delta antigen (SHDAg) and the large hepatitis delta antigen (LHDAg), on $NF-{\kappa}B$ signaling pathway. In this study, we demonstrated that $TNF-{\alpha}-induced$ $NF-{\kappa}B$ transcriptional activation was increased by LHDAg but not by SHDAg in both HEK293 and Huh7 cells. Furthermore, LHDAg promoted TRAF2-induced $NF-{\kappa}B$ activation. Using coimmunoprecipitation assays, we demonstrated that both SHDAg and LHDAg interacted with TRAF2 protein. We showed that isoprenylation of LHDAg was not required for the increase of $NF-{\kappa}B$ activity. We further showed that only LHDAg but not SHDAg increased the $TNF-{\alpha}-mediated$ nuclear translocation of p65. This was accomplished by activation of $I{\kappa}B_{\alpha}$ degradation by LHDAg. Finally, we demonstrated that LHDAg augmented the COX-2 expression level in Huh7 cells. These data suggest that LHDAg modulates $NF-{\kappa}B$ signaling pathway and may contribute to HDV pathogenesis.

Keywords

Acknowledgement

Supported by : Ministry of Health and Welfare, NRL, Ministry of Education, Science and Technology

References

  1. Aggarwal, B.B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208 https://doi.org/10.1016/j.ccr.2004.09.003
  2. Baeuerle, P.A., and Baltimore, D. (1996). NF-kappa B: ten years after. Cell 87, 13-20 https://doi.org/10.1016/S0092-8674(00)81318-5
  3. Baldwin, A.S.Jr. (1996). The NF-kappa B and IkappaB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683 https://doi.org/10.1146/annurev.immunol.14.1.649
  4. Barnes, P.J., and Karin, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071 https://doi.org/10.1056/NEJM199704103361506
  5. Casey, J.L., and Gerin, J.L. (1995). Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Virol. 69, 7593-7600
  6. Chang, F.L., Chen, P.J., Tu, S.J., Wang, C.J., and Chen, D.S. (1991). The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc. Natl. Acad. Sci. USA 88, 8490-8494 https://doi.org/10.1073/pnas.88.19.8490
  7. Chao, M., Hsieh, S.Y., and Taylor, J. (1990). Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of selflimiting genome replication. J. Virol. 64, 5066-5069
  8. Chen, P.J., Chang, F.L., Wang, C.J., Lin, C.J., Sung, S.Y., and Chen, D.S. (1992). Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the aminoterminal leucine zipper. J. Virol. 66, 2853-2859
  9. Choi, S.H., Park, K.J., Ahn, B.Y., Jung, G., Lai, M.M.C., and Hwang, S.B. (2006). Hepatitis C virus ninstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular I-$\kappa$B kinase. Mol. Cell. Biol. 26, 3048-3059 https://doi.org/10.1128/MCB.26.8.3048-3059.2006
  10. Chung, Y.M., Park, K.J., Choi, S.Y., Hwang, S.B., and Lee, S.Y. (2001). Hepatitis C virus core protein potentiates TNF-$\alpha$-induced NF-$\kappa$B activation through TRAF2-IKK$\beta$-dependent pathway. Biochem. Biophys. Res. Commun. 284, 15-19 https://doi.org/10.1006/bbrc.2001.4936
  11. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. (1997). A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548-554 https://doi.org/10.1038/41493
  12. Farci, P. (2003). Delta hepatitis: an update. J. Hepatol. 39, S212-S219 https://doi.org/10.1016/S0168-8278(03)00331-3
  13. Fernholz, D., Galle, P.R., Stemler, M., Runetto, M.B., Bonino, F., and Will, H. (1993). Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194, 137-148 https://doi.org/10.1006/viro.1993.1243
  14. Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109, S81-S96 https://doi.org/10.1016/S0092-8674(02)00703-1
  15. Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260 https://doi.org/10.1146/annurev.immunol.16.1.225
  16. Glenn, J.S., Watson, J.A., Havel, C.M., and White, J.M. (1992). Identification of a prenylation site in delta virus large antigen. Science 256, 1331-1333 https://doi.org/10.1126/science.1598578
  17. Hideo, Y., Kato, N., Shiratori, Y., Otsuka, M., Maeda, S., Kato, J., and Omata, M. (2001). Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J. Biol. Chem. 276, 16399-16405 https://doi.org/10.1074/jbc.M006671200
  18. Hwang, S.B., and Lai, M.M.C. (1993). Isoprenylation mediates direct proteinprotein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J. Virol. 67, 7659-7662
  19. Hwang, S.B., Lee, C.Z., and Lai, M.M.C. (1992). Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 190, 413-422 https://doi.org/10.1016/0042-6822(92)91227-L
  20. Hwang, S.B., Park, K.J., and Kim, Y.S. (1998). Overexpression of hepatitis delta antigen protects insect cells from baculovirus-induced cytolysis. Biochem. Biophys. Res. Commun. 244, 652-658 https://doi.org/10.1006/bbrc.1998.8317
  21. Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-$\kappa$B activity. Annu. Rev. Immunol. 18, 621-663 https://doi.org/10.1146/annurev.immunol.18.1.621
  22. Kos, A., Dijkema, R., Arnberg, A.C., Van der Meide, P.H., and Schellekens, H. (1986). The hepatitis delta ($\delta$) virus possesses a circular RNA. Nature 323, 558-560 https://doi.org/10.1038/323558a0
  23. Kuo, M.Y., Chao, M., and Taylor, J. (1989). Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J. Virol. 63, 1945-1950
  24. Lai, M.M.C. (1995). The molecular biology of hepatitis delta virus. Annu. Rev. Biochem. 64, 259-286 https://doi.org/10.1146/annurev.bi.64.070195.001355
  25. Lee, C.Z., Chen, P.J., Lai, M.M., and Chen, D.S. (1994). Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly. Virology 199, 169-175 https://doi.org/10.1006/viro.1994.1109
  26. Lee, S.Y., Lee, S.Y., Kandala, G., Liou, M.-L., Liou, H.C., and Choi. Y. (1997). CD30/TNF receptor-associated factor interaction: NFkappaB activation and binding specificity. Proc. Natl. Acad. Sci. USA 93, 9699-9703
  27. Luo, G.X., Chao, M., Hsieh, S.Y., Sureau, C., Nishikura, K., and Taylor, J. (1990). A specific base transition occurs on replicating hepatitis delta virus RNA. J. Virol. 64, 1021-1027
  28. Makino, S., Chang, M.F., Shieh, C.K., Kamahora, T., Vannier, D.M., Govindarajan, S., and Lai, M.M.C. (1987). Molecular cloning and sequencing of a human hepatitis delta ($\delta$) virus RNA. Nature 329, 343-346 https://doi.org/10.1038/329343a0
  29. Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B.L., Li, J., Young, D.B., Barbosa, M., Mann, M., Manning, A., et al. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866 https://doi.org/10.1126/science.278.5339.860
  30. Mizuno, T., Kaibuchi, K., Yamamoto, T., Kawamura, M., Sakoda, T., Fujioka, H., Matsuura, Y., and Takai, Y. (1991). A stimulatory GDP/GTP exchange protein for smg p21 is active on the posttranslationally processed form of c-Ki-ras p21 and rhoA p21 Proc. Natl. Acad. Sci. USA 88, 6442-6446 https://doi.org/10.1073/pnas.88.15.6442
  31. Niro, G.A., Rosina, F., and Rizzetto, M. (2005). Treatment of hepatitis D. J. Viral. Hepat. 12, 2-9 https://doi.org/10.1111/j.1365-2893.2005.00601.x
  32. Park, K.J., Choi, S.H., Koh, M.S., Kim, D.J., Yie, S.W., Lee, S.Y., and Hwang, S.B. (2001). Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2. Virus Res. 74, 89-98 https://doi.org/10.1016/S0168-1702(00)00251-3
  33. Park, K.J., Choi, S.H., Lee, S.Y., Hwang, S.B., and Lai, M.M.C. (2002). Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor $\alpha$-stimulated nuclear factor $\kappa$B activation. J. Biol. Chem. 277, 13122-13128 https://doi.org/10.1074/jbc.M111599200
  34. Park, C.Y., Jun H.J., Wakita T., Cheong J.H., and Hwang, S.B. (2009). Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J. Biol. Chem. 284, 9237-9246 https://doi.org/10.1074/jbc.M808773200
  35. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., and Rothe, M. (1997). Identification and characterization of an IkappaB kinase. Cell 90, 373-383 https://doi.org/10.1016/S0092-8674(00)80344-X
  36. Rizzetto, M., Hoyer, B., Canese, M.G., Shih, J.W., Purcell, R.H., and Gerin, J.L. (1980). Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of deltainfected chimpanzees. Proc. Natl. Acad. Sci. USA 77, 6124-6128 https://doi.org/10.1073/pnas.77.10.6124
  37. Rothwarf, D.M., Zandi, E., Natoli, G., and Karin, M. (1998). IKKgamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395, 297-300 https://doi.org/10.1038/26261
  38. Ryu, W.S., Bayer, M., and Taylor, J.M. (1992). Assembly of hepatitis delta virus particles. J. Virol. 66, 2310-2315
  39. Shrivastava, A., Manna, S.K., Ray, R., and Aggarwal, B.B. (1998). Etopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol. 72, 9722-9728
  40. Silverman, N., and Maniatis, T. (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321-2342 https://doi.org/10.1101/gad.909001
  41. Thanos, D., and Maniatis, T. (1995). NF-kappaB: a lesson in family values. Cell 80, 529-532 https://doi.org/10.1016/0092-8674(95)90506-5
  42. Wang, K.S., Choo, Q.L., Weiner, A.J., Ou, J.H., Najarian, R.C., Thayer, R.M., Mullenbach, G.T., Denniston, K.J., Gerin, J.L., and Houghton, M. (1986). Structure, sequence, and expression of the hepatitis delta (delta) viral genome. Nature 323, 508-514 https://doi.org/10.1038/323508a0
  43. Weil, R., Sirma, H., Giannini, C., Kremsdorf, D., Bessia, C., Dargemont, C., Brechot, C., and Israel, A. (1999). Direct association and nuclear import of the hepatitis B virus X protein with the NF-$\kappa$B inhibitor I$\kappa$B$\alpha$. Mol. Cell. Biol. 19, 6345-6354
  44. Whiteside, S.T., and Israel, A. (1997). IkappaB proteins: structure, function and regulation. Semin. Cancer Biol. 8, 75-82 https://doi.org/10.1006/scbi.1997.0058
  45. Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D.V. (1997). IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278, 866-869 https://doi.org/10.1126/science.278.5339.866
  46. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., Agou, F., Kirk, H.E., Kay, R.J., and Israel, A. (1998). Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93, 1231-1240 https://doi.org/10.1016/S0092-8674(00)81466-X
  47. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., and Karin, M. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91, 243-252 https://doi.org/10.1016/S0092-8674(00)80406-7
  48. Zandi, E., Chen, Y., and Karin, M. (1998). Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB bound substrate. Science 281, 1360-1363 https://doi.org/10.1126/science.281.5381.1360
  49. Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., and Lai, M.M.C. (1998). Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72, 3691-3697

Cited by

  1. Interaction of Host Cellular Proteins with Components of the Hepatitis Delta Virus vol.2, pp.1, 2009, https://doi.org/10.3390/v2010189
  2. Hepatitis B Virus e Antigen Downregulates Cytokine Production in Human Hepatoma Cell Lines vol.23, pp.5, 2009, https://doi.org/10.1089/vim.2010.0042
  3. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus vol.20, pp.40, 2014, https://doi.org/10.3748/wjg.v20.i40.14589
  4. Hepatitis D and hepatocellular carcinoma vol.7, pp.5, 2015, https://doi.org/10.4254/wjh.v7.i5.777
  5. Hepatitis delta virus and hepatocellular carcinoma: an update vol.146, pp.13, 2018, https://doi.org/10.1017/s0950268818001942
  6. Insight into the Contribution and Disruption of Host Processes during HDV Replication vol.11, pp.1, 2009, https://doi.org/10.3390/v11010021
  7. Regulation of NF-Kappa B Signaling Pathway by Hepatitis Viruses vol.10, pp.3, 2009, https://doi.org/10.12677/hjbm.2020.103006
  8. HDV Pathogenesis: Unravelling Ariadne’s Thread vol.13, pp.5, 2009, https://doi.org/10.3390/v13050778
  9. AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis vol.13, pp.5, 2009, https://doi.org/10.3390/v13050788
  10. Hepatitis D Virus and Hepatocellular Carcinoma vol.13, pp.5, 2009, https://doi.org/10.3390/v13050830